REQUEST A DEMO
Total
USD $0.00
Search more companies

Lock Pharma Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Lock Pharma Sp. z o.o. Profile Updated: May 23, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Lock Pharma Sp. z o.o. is an enterprise located in Poland, with the main office in Adamowek. The company operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was incorporated on January 22, 2014. Lock Pharma Sp. z o.o. currently employs 1 (2015) people. The company’s latest financial report indicates a net sales revenue increase of 20.27% in 2023. There was a total growth of 15.93% in Lock Pharma Sp. z o.o.’s total assets over the same period. Lock Pharma Sp. z o.o.’s net profit margin decreased by 0.12% in 2023.

Headquarters
Ul. Prosta 33
Adamowek; Mazowieckie; Postal Code: 05-152

Contact Details: Purchase the Lock Pharma Sp. z o.o. report to view the information.

Website: http://www.lockpharma.pl

Basic Information
Total Employees:
Purchase the Lock Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Lock Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Lock Pharma Sp. z o.o. report to view the information.
Incorporation Date:
January 22, 2014
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
99.51%
Subsidiaries
Acme Partners Sp. z o.o.
80%
Company Performance
Financial values in the chart are available after Lock Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
20.27%
Total operating revenue
20.67%
Operating profit (EBIT)
25.36%
EBITDA
30.94%
Net Profit (Loss) for the Period
16.57%
Total assets
15.93%
Total equity
4.47%
Operating Profit Margin (ROS)
0.19%
Net Profit Margin
-0.12%
Return on Equity (ROE)
0.45%
Debt to Equity Ratio
-0.93%
Quick Ratio
-0.43%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?